In an analysis of farnesyltransferase inhibition, Li et al. found that farnesyltransferase inhibition attenuated myocardial fibrosis and improved VR in SHRs partly through suppression of the ERK1/2 phosphorylation pathway [46]. This evidence concerns the gene MAPK3 and Myocardial fibrosis.